Millipore Sigma Vibrant Logo

371970 HA 1077, Dihydrochloride - CAS 103745-39-7 - Calbiochem

A cell-permeable, reversible, and ATP-competitive Ca2+ antagonist with anti-vasospastic properties.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: Fasudil, (5-Isoquinolinesulfonyl)homopiperazine, 2HCl, PKG Inhibitor VII

Primary Target: PKA
View Products on Sigmaaldrich.com
371970
查看价格及供货情况

概述

Replacement Information

重要规格表

CAS #Empirical Formula
103745-39-7C₁₄H₁₇N₃O₂S · 2HCl

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
371970-1MGCN
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 塑胶安瓿;塑胶针药瓶 1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable, reversible, and ATP-competitive Ca2+ antagonist with anti-vasospastic properties. Inhibits protein kinase A (Ki = 1.6 µM), protein kinase G (Ki = 1.6 µM), and myosin light chain kinase (Ki = 36 µM). Also reported to potently inhibit Rho-associated kinase (ROCK; IC50 = 10.7 µM). Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency.
      Catalogue Number371970
      Brand Family Calbiochem®
      SynonymsFasudil, (5-Isoquinolinesulfonyl)homopiperazine, 2HCl, PKG Inhibitor VII
      References
      ReferencesWatanabe, K., et al. 2007. Nature Biotech. 25, 681.
      Swärd, K., et al. 2000. J. Physiol. 522, 33.
      Takizawa, S., et al. 1993. Eur. J. Pharmacol. 250, 431.
      Seto, M., et al. 1991. Eur. J. Pharmacol. 195, 267.
      Shirotani, M., et al. 1991. J. Pharmacol. Exp. Ther. 259, 738.
      Asano, T., et al. 1990. Eur. J. Pharmacol. 190, 365.
      Sasaki, Y., and Sasaki, Y. 1990. Biochem. Biophys. Res. Commun. 171, 1182.
      Asano, T., et al. 1989. Br. J. Pharmacol. 98, 1091.
      Product Information
      CAS number103745-39-7
      ATP CompetitiveY
      FormWhite solid
      Hill FormulaC₁₄H₁₇N₃O₂S · 2HCl
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKA
      Primary Target IC<sub>50</sub>10.7 µM inhibiting Rho-associated kinase (ROCK)
      Primary Target K<sub>i</sub>.6 µM, 1.6 µM, 36 µM, inhibiting protein kinase A, protein kinase G, myosin light chain kinase, respectively
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      371970-1MGCN 04055977213539

      Documentation

      HA 1077, Dihydrochloride - CAS 103745-39-7 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      HA 1077, Dihydrochloride - CAS 103745-39-7 - Calbiochem 分析证书

      标题批号
      371970

      参考

      参考信息概述
      Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
      Swärd, K., et al. 2000. J. Physiol. 522, 33.
      Takizawa, S., et al. 1993. Eur. J. Pharmacol. 250, 431.
      Seto, M., et al. 1991. Eur. J. Pharmacol. 195, 267.
      Shirotani, M., et al. 1991. J. Pharmacol. Exp. Ther. 259, 738.
      Asano, T., et al. 1990. Eur. J. Pharmacol. 190, 365.
      Sasaki, Y., and Sasaki, Y. 1990. Biochem. Biophys. Res. Commun. 171, 1182.
      Asano, T., et al. 1989. Br. J. Pharmacol. 98, 1091.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-January-2010 RFH
      SynonymsFasudil, (5-Isoquinolinesulfonyl)homopiperazine, 2HCl, PKG Inhibitor VII
      DescriptionA cell-permeable, reversible, and ATP-competitive Ca2+ antagonist with anti-vasospastic properties. Inhibits protein kinase A (Ki = 1.6 µM), protein kinase G (Ki = 1.6 µM), and myosin light chain kinase (Ki = 3.6 µM). Also reported to potently inhibit Rho-associated kinase (ROCK; IC50 = 10.7 µM). Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency.
      FormWhite solid
      CAS number103745-39-7
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (1 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Toxicity Harmful
      ReferencesWatanabe, K., et al. 2007. Nature Biotech. 25, 681.
      Swärd, K., et al. 2000. J. Physiol. 522, 33.
      Takizawa, S., et al. 1993. Eur. J. Pharmacol. 250, 431.
      Seto, M., et al. 1991. Eur. J. Pharmacol. 195, 267.
      Shirotani, M., et al. 1991. J. Pharmacol. Exp. Ther. 259, 738.
      Asano, T., et al. 1990. Eur. J. Pharmacol. 190, 365.
      Sasaki, Y., and Sasaki, Y. 1990. Biochem. Biophys. Res. Commun. 171, 1182.
      Asano, T., et al. 1989. Br. J. Pharmacol. 98, 1091.

      相关产品和应用

      种类

      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Rho Kinase (ROCK) Inhibitors